Agios Pharmaceuticals (AGIO) Other Accumulated Expenses (2012 - 2017)
Agios Pharmaceuticals (AGIO) reported Other Accumulated Expenses of $1.3 million for Q1 2017, up 386.8% from $266,000 a year earlier and up 670.8% from the prior quarter.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Other Accumulated Expenses (2012 - 2017) Analysis & Trends
At the end of FY2016, Agios Pharmaceuticals posted Other Accumulated Expenses of $168,000, down 87.2% from FY2015.
- Other Accumulated Expenses has a four-year compound annual growth rate of 26.8% (FY2012 to FY2016).
- By year, Other Accumulated Expenses came in at $1.31 million in FY2015 (+197.3%), $442,000 in FY2014 (+215.7%), $140,000 in FY2013 (+115.4%) and $65,000 in FY2012.
- The Q1 2017 figure ranks as the highest quarterly Other Accumulated Expenses since Q4 2015.
- Year over year, Other Accumulated Expenses gained in four of the last eight quarters, with growth averaging 132.5%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q2 2015 (growth of 708.6%); the low point was Q4 2016 (a decline of 87.2%).
- Per Business Quant data, the three quarters before Q1 2017 came in at $168,000 (Q4 2016), $538,000 (Q3 2016) and $207,000 (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Agios Pharmaceuticals | 1.90 Bn | 1.90 Bn | 41.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 168,000.00 |
| Sep 30, 2016 | 538,000.00 |
| Jun 30, 2016 | 207,000.00 |
| Mar 31, 2016 | 266,000.00 |
| Dec 31, 2015 | 1.31 Mn |
| Sep 30, 2015 | 356,000.00 |
| Jun 30, 2015 | 752,000.00 |
| Mar 31, 2015 | 641,000.00 |
| Dec 31, 2014 | 442,000.00 |
| Sep 30, 2014 | 1.04 Mn |
| Jun 30, 2014 | 93,000.00 |
| Mar 31, 2014 | 624,000.00 |
| Dec 31, 2013 | 140,000.00 |
| Sep 30, 2013 | 426,000.00 |
| Jun 30, 2013 | 415,000.00 |
| Dec 31, 2012 | 65,000.00 |
API Access
Agios Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AGIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();